Durability of Humoral Responses after the Second Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care Facility

Durability of Humoral Responses after the Second Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care Facility

Residents of long-term care facilities (LTCFs) have been dramatically hit by the COVID-19 pandemic on a global scale as older age and comorbidities pose an increased risk of severe disease and death. The aim of the study was to assess the quantity and durability of specific antibody responses to SAR...

Full description

Bibliographic Details
Main Authors: Alessia Lai, Barbara Caimi, Marco Franzetti, Annalisa Bergna, Rossella Velleca, Antonella Gatti, Pier Luigi Rossi, Marco D’Orso, Fabrizio Pregliasco, Claudia Balotta, Giuseppe Calicchio
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Vaccines
Subjects:
long-term care facilities
humoral responses
nucleocapsid serology
COVID-19
vaccines
Online Access:https://www.mdpi.com/2076-393X/10/3/446

Similar Items

Similar Items